evaluated the PPARγ-mediated effects of CBD on l-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesia, a mouse model of Parkinson’s disease. The gene discussed is PPARG; the disease is drug-induced dyskinesia.